Indonesia Pharmacy Retail Consumer Experience Sample Report Ken Research
                     October 
2025
Indonesia Pharmacy Retail 
Market Outlook To 2025
By Market Structure (Organized & 
Unorganized); By Region (West Java , 
East Java , Central Java , Jakarta , 
North Sumatra & Others); By 
Product Categories (Prescribed, OTC, 
Non- Pharmaceutical Products & 
Medical Equipment); By Therapeutic 
Areas; and By Product Type 
(Patented & Generic Drugs)
Author: Madhur Chopra  |  Vertical: Healthcare  |  
Region: Asia
Shaped by Rising Healthcare Expenditure, Expanding Insurance Coverage, Aging Population & 
Chronic Disease Burden.
Table of 
Contents
1 1. Executive 
Summary
1.1 Executive Summary of Indonesia Pharmacy Retail 
Market
2 2. Market Size 
Overview
1. Market Volume
2. Market Revenue
3. Historical Data (2015–2020)
4. Forecast (2020–2025) and 5-Year 
CAGR
3 3. Market Segmentation of Indonesia Pharmacy Retail, 
2025
1. Segmentation by Product Type: (Prescription Drugs, OTC Drugs, Health & Wellness)
2. Segmentation by Distribution Channel: (Traditional Pharmacies, Modern Pharmacies, E-commerce 
Pharmacies)
3. Segmentation by Geographic Region: (Java, Sumatra, Kalimantan, Sulawesi)
4. Segmentation by Therapeutic Area: (Oncology, Neurology, Gastroenterology, Cardiology)
5. Segmentation by Consumer Demographics: (Age Groups, Income Tiers, Gender, Education Level)
4 4. Industry 
Analysis
1. Growth & Value Drivers
1. Rising Healthcare Expenditure
2. Expanding Insurance Coverage
3. Aging Population & Chronic Disease 
Burden
4. Urbanization & Retail Penetration
2. Industry Challenges
1. Regulatory Complexity & Compliance 
Costs
2. Price Controls & Reimbursement 
Pressures
3. Supply Chain Disruptions
4. Intense Competition & Margin Erosion
3. Opportunities
1. Digital Transformation & Telepharmacy
2. Specialty Pharmacy Services
3. Rural Market Expansion
4. Private-Label & Retail Brand 
Development
4. Emerging Trends
1. Omni-Channel Retailing
2. Data-Driven Customer 
Engagement
3. Health & Wellness Integration
4. Consolidation & M&A Activity
5 5. Value Chain & Industry 
Taxonomy
1. Pharmacy Retail Value 
Chain
1. Sourcing & Procurement
2. Distribution & Logistics
3. Retail Operations
4. Marketing & Sales
5. After-Sales Services
2. Industry Taxonomy
1. Upstream Suppliers 
(API, Finished 
Dosage)
2. Distributors & 
Wholesalers
3. Retail Outlets & 
Formats
6 6. Regulatory 
Frame4w.ork End-Customer 
Segments
1. Key Regulatory Bodies (BPOM, Ministry of 
Health)
2. Licensing & Accreditation Requirements
3. Pricing & Reimbursement Policies
4. Quality Standards & Good Pharmacy Practice 
(GPP)
5. Import/Export Controls & Tariffs
7 7. Competitive Landscape of the Indonesia Pharmacy 
Retail
1. Major Companies Covered: (PT Kimia Farma Tbk, PT Guardian Health & Beauty, PT Watsons Indonesia, 
PT Century Healthcare Tbk, Apotek K-24, and Others)
2.Operational Parameters: (Company, Headquarter, Market Share (%), Total Revenue (USD Mn), Revenue 
Growth Rate (%), EBITDA Margin (%), and Others)
3. Financial Parameters: Market Shares, Revenues, and Profit Margins
8 8. Future Market Segmentation of Indonesia Pharmacy Retail, 
2030
1. Segmentation by Product Type: (Prescription Drugs, OTC Drugs, Health & Wellness)
2. Segmentation by Distribution Channel: (Traditional Pharmacies, Modern Pharmacies, E-commerce 
Pharmacies)
3. Segmentation by Geographic Region: (Java, Sumatra, Kalimantan, Sulawesi)
4. Segmentation by Therapeutic Area: (Oncology, Neurology, Gastroenterology, Cardiology)
5. Segmentation by Consumer Demographics: (Age Groups, Income Tiers, Gender, Education Level)
9 9. Analyst 
Recommendations
1. TAM/SAM/SOM Analysis
2. Go-to-Market Strategies
3. Partnership & M&A Opportunities
4. Digital & Omnichannel Roadmap
5. Risk Mitigation & Regulatory 
Compliance
1 10. Research 
Methodology
0
1. Data Sources & Validation
2. Primary Research Approach
3. Secondary Research 
Framework
4. Forecasting Model & 
Assumptions
5. Limitations & Data Gaps
1 11. 
Disclaimer
1
12. Contact 
Us
1
2
0
1
Executive 
Summary
Executive Summary
Exhibit 1.1
Taxonomy & Market Size of Indonesia Pharmacy Retail 
Market
Indonesia Pharmacy Retail 
Market (USD XX Bn)
By Product Type By Distribution Channel
Prescription Drugs OTC Drugs Health & Wellness Traditional Modern E-
XX% XX% XX% Pharmacie Pharmacie commerce 
Pharmacies 
Medicines Non- Supplements, s XX% s XX%
XX%
requiring a prescription herbal & 
doctor’s medicines for beauty 
prescription minor ailments. products. Single-outlet Branded Online 
. or small group chains, platforms, 
stores. supermarkets mobile apps.
with pharmacy 
Analgesics Dietary 
counters.
Cardiovascula & Supplement
r (XX%) Antipyretics s (XX%) Pure-Play 
(XX%) Online 
Independen Pharmacie
t National/ s (XX%)
Herbal & Pharmacies Regional 
Cough & 
Anti- Traditiona (XX%) Pharmac
Cold 
infectives l (XX%) y Chains Omnichann
Preparations 
(XX%) Hospital- (XX%) el Players 
(XX%) Based (XX%)
Pharmacie
Sports s (XX%) Supermarket
Respirator Gastrointestin Nutritio / Marketplac
y (XX%) al (XX%) n (XX%) Hypermarket e 
Kiosk- Pharmacy Pharmacies
Style Counters (XX%)
Outlets (XX%)
(XX%)
Convenienc
e Store 
Pharmacies 
(XX%)
By Geographic Java Kalimanta Sulawesi
Region Sumatra n
By Therapeutic Oncology Neurology Gastroenterology
Area Cardiology
By Consumer Age Income Gende Education 
Demographics Groups Tiers r Level
Source: Ken Research Analysis
Note 1: Exhibits are illustrative; detailed numbers appear in the full 
report.
Note 2: XX% denotes CAGR.
COPYRIGHT KEN RESEARCH. ALL RIGHTS 
RESERVED
02
Indonesia Pharmacy 
Retail Market 
Outlook
Indonesia Pharmacy Retail Market Outlook
Indonesia Pharmacy Retail Market Scenario
The Indonesia pharmacy retail market is rapidly evolving, driven by rising health awareness, expanded 
insurance coverage and digitalization. Traditional brick-and-mortar chains are integrating e-commerce 
platforms, leveraging mobile apps and telepharmacy services to enhance customer reach. Key value drivers 
include demographic shifts, growing chronic disease prevalence and government initiatives to bolster 
universal healthcare access. Tailwinds such as rising middle- class incomes, regulatory support for online 
drug distribution and seamless fintech payments catalyze growth. In the next five years, consolidation 
among local players, increased private equity investment and advanced data analytics implementation 
reshape market dynamics, yielding omnichannel expansion and innovation.
Exhibit 2.1
Illustrative Indonesia Pharmacy Retail Market Overview
CAGR: XX%
XX% XX%
XX% XX%
XX% XX%
XX% XX%
XX% XX%
XX% XX%
2025 2030
By Product Type Prescription Drugs OTC Health & 
Drugs Wellness
By Distribution Channel Traditional Modern E-commerce 
Pharmacies Pharmacies Pharmacies
Source: Ken Research Analysis
Note 1: The exhibit serves as an illustration, with numbers currently masked. The detailed statistics will be included in the final 
report.
Note 2: All revenue and financial numbers are for current year and financial year, i.e., 2025 & 2030.
Note 3: XX% in the above exhibit denotes market size.
COPYRIGHT KEN RESEARCH. ALL RIGHTS 
RESERVED
03
Market Segmentation 
of Indonesia Pharmacy 
Retail Market
Market Segmentation of Indonesia Pharmacy Retail Market
Indonesia Pharmacy Retail Market Segmentation
Indonesia Pharmacy Retail Market to 2025 is segmented by: By Product Type – Prescription Drugs (XX%) and OTC 
Drugs (XX%), with Prescription Drugs driving value growth via antidiabetics and cardiovascular therapies. By 
Distribution Channel – National/ Regional Pharmacy Chains (XX%) and Pure-Play Online Pharmacies (XX%), as chains 
expand footprints and e-commerce adoption surges. By Geographic Region – Java (XX%) and Sumatra (XX%), led by 
urban demand in Java. Top segments performance is anchored by chronic-care prescriptions and digital OTC sales. 
Growth opportunities include telepharmacy services and expansion into Sulawesi. Recent developments involve 
retailer–logistics partnerships and omnichannel platform launches.
Exhibit 3.1
Illustrative Market Segmentation of Indonesia Pharmacy Retail Market
Sulawes Cardiolog Education 
E- Convenience 
Health & Respirator i XX% y XX% Level 
commerce Store XX%
Wellness y (XX
Pharmacies Pharmacies 
XX% %)
XX% (XX%)
Gende
r XX
Kalimanta Gastroenterolog %
n XX% y XX%
Supermarket
Modern / 
Anti- Income 
Pharmacie Hypermarket 
OTC infectives Tiers s XX% Pharmacy 
Drugs (XX%) XX%Counters 
XX% (XX%) Sumatr Neurolog
a XX% y XX
%
Age 
Prescription Groups 
Drugs XX XX%
% Traditional 
Pharmacie National/Regiona Java 
Cardiovascula s XX% l Pharmacy XX Oncolog
r (XX%) Chains (XX%) % y XX
%
By Product Prescription By Modern By By Therapeutic
Type Drugs Distributio Pharmacie Geographi By Consumer 
n Channel s c Region Area Demographics
Key Takeaways:
Prescription Drugs are driving value 
growth. E-commerce adoption is 
surging.
Urban demand in Java is leading growth. 
Opportunities include telepharmacy 
seSrovuricee: sKe.n Research Analysis
Note 1: This exhibit serves as a visual representation. The final chart will include additional segments along with detailed 
statistics in the final report.
Note 2: All revenue and financial numbers are for the current year.
Note 3: "XX%" in the above exhibit denotes market shares.
COPYRIGHT KEN RESEARCH. ALL RIGHTS 
RESERVED
04
Overview And Genesis 
Of The Indonesia 
Pharmacy Retail Market
Overview And Genesis Of The Indonesia Pharmacy Retail Market
Indonesia Pharmacy Retail Market Ecosystem
Indonesia’s pharmacy retail ecosystem comprises large, medium and small enterprises. Large chains 
(Kimia Farma, Century, K24) leverage omnichannel distribution and loyalty programs to serve urban mass 
markets, relying on manufacturer partnerships and CRM systems to drive product sales and health 
services at scale. Medium players (regional networks like Apotek Surya) target local demographics with 
hybrid online–offline channels, mid-sized inventories, third-party logistics and niche healthcare partnerships. 
Small independent pharmacies prioritize personalized service for neighborhood customers, lean cost 
structures and direct supplier agreements, offering quick dispensing and basic consultations. Each 
segment’s business model canvas balances value propositions, customer segments, channels, key 
partnerships, cost structures and revenue streams.
Exhibit 4.1
Illustrative Ecosystem of Indonesia Pharmacy Retail Market
Entity type Revenue Streams Players
PT Kimia Farma Tbk 
▶  Prescription (Rx) medicines
(Apotek Kimia 
Community Pharmacy ▶  Over-the-counter (OTC) Farma) Apotek K-24
Chains (Apotek Ritel) drugs Century 
▶  Health supplements & Healthcare 
vitamins (Apotek Century) 
Apotek Melawai
▶  Personal care & beauty Guardian Indonesia 
▶pr o OduTCct smedicines & fi rst-aid items Watsons Indonesia 
Drugstores / Health & ▶  Nutraceuticals & dietary The Body Shop 
Beauty Retailers supplements (selected outlets) 
▶  Skincare & cosmetics The Medicine 
Shoppe 
▶  Personal care & hygiene products
International
Siloam 
Hospitals 
▶  Inpatient & outpatient Rx dispensing
Group
▶ Compounding & IV admixtures Mitra 
Hospital Pharmacies
▶  Specialized therapies (oncology, biologics) Keluarga 
Hospitals
▶  Clinical pharmacy services & medication 
RSUD Dr. 
counseling
Soetomo 
(Surabaya)
▶  Digital Rx fulfilment (teleconsult + e- RHSa lPoodnodco k 
prescription) Alodokter 
Online Pharmacies / Indah Group
E- commerce ▶  OTC & wellness product e-sales
GoApotik 
(Gojek)
Platforms ▶  Home/offi ce delivery & subscription models K24Klik (Apotek K-
▶  Mobile-app consultations & booking 24 digital)
▶  Limited OTC & fi rst-aid items Indomare
Convenience Stores ▶  Vitamins & basic supplements
t 
Alfamart
& Hypermarkets ▶  Personal care & hygiene merchandise Circle K Indonesia 
▶  Impulse-buy health products (e.g., pain Hypermart 
relief) (Health & Beauty 
aisle)
COPYRIGHT KEN RESEARCH. ALL RIGHTS 
RESERVED
05
Competitive 
Landscape
Competitive Landscape (1/3)
Competitive Landscape Overview
Indonesia’s pharmacy retail market is led by state-owned Kimia Farma, Century, Guardian and K24. Kimia Farma 
leverages integrated manufacturing and hospital partnerships (key resources), offering affordable generics 
via outlets and e- commerce (channels) with government partnerships, funded by sales. Century’s multi-
channel network (key activities) targets urban professionals with branded medicines, leveraging supplier 
alliances and membership programs (customer relationships). Guardian focuses on health and wellness in 
premium malls, backed by Dairy Farm’s buying scale and loyalty rewards. K24 operates a 24-hour franchise 
model, emphasizing convenience, teleconsultation services and digital ordering. All incur inventory and 
staffi ng costs, competing on location, assortment and pricing.
Exhibit 5.1
Illustrative Market Shares of Key Players in Indonesia Pharmacy Retail Market
Note: These are illustrative representations and do not reflect actual data or real-world figures
Source: Ken Research Analysis
Note 1: The XX% in the exhibit represents the market share of each 
company. Note 2: The exhibit serves as an illustration, with numbers 
currently masked. Note 3: All revenue and financial numbers are for the 
current year.
COPYRIGHT KEN RESEARCH. ALL RIGHTS 
RESERVED
Competitive Landscape (2/3)
Exhibit 5.2
Illustrative Competition Matrix of Indonesia Pharmacy Retail Market
Major Players in Indonesia Pharmacy Retail Market
Figure represents cumulative market share for only the product 
segment.:
Indonesia Pharmacy Retail 
Market: USD XX Bn
Note: These are illustrative representations and do not reflect 
actual data or real-world figures
Large Medium Small 
Players Players Players
Source: Ken Research Analysis
Note 1: The XX% in the exhibit shows the market share of each company, which represents the company’s contribution to the total 
market.
Note 2: The exhibit serves as an illustration, with numbers currently masked.
Note 3: All revenue and financial numbers are for the current year.
Note 4: Enterprise size categories based on annual revenue in US€—Large > 1Bn; Medium 100Mn–1Bn; Small < 100Mn
COPYRIGHT KEN RESEARCH. ALL RIGHTS 
RESERVED
Competitive Landscape (3/3)
Exhibit 5.3
Illustrative Cross Comparison of Key Players in Indonesia Pharmacy Retail 
Market
Total Store E- Inventory 
Market Revenue EBITDA
Revenue Network commerce Turnover 
Company Headquarter Share Growth Margin 
(USD Size Penetration (Times/ 
(%) Rate (%)
Mn) (Outlets) (%) year)
(%)
PT Kimia Jakarta, 
XX% XX XX% XX% XX XX% XX
Farma Indonesi
Tbk a
PT
Guardian Jakarta, XX% XX XX% XX% XX XX% XX
Health & Indonesia
Beauty
PT
Jakarta, 
Watsons XX% XX XX% XX% XX XX% XX
Indonesi
Indonesi
a
a
PT 
Jakarta, 
Century XX% XX XX% XX% XX XX% XX
Indonesi
Healthcar
a
e Tbk
Apote Yogyakarta, 
XX% XX XX% XX% XX XX% XX
k K-24 Indonesia
Jakarta, 
GoApotik XX% XX XX% XX% XX XX% XX
Indonesi
a
Apotek Jakarta, 
XX% XX XX% XX% XX XX% XX
Melaw Indonesi
ai a
Jakarta, 
Prosehat XX% XX XX% XX% XX XX% XX
Indonesi
a
Jakarta, 
Alodokter XX% XX XX% XX% XX XX% XX
Indonesi
a
Jakarta, 
Farmaku XX% XX XX% XX% XX XX% XX
Indonesi
a
Source: Ken Research Analysis
Note 1: The XX% and XX values in the exhibit represent placeholder data and will be replaced with actual figures in the final 
report.
Note 2: All revenue and financial numbers are for the current year.
COPYRIGHT KEN RESEARCH. ALL RIGHTS 
RESERVED
06
Analyst 
Recommendation
Analyst Recommendation
TAM/SAM & SOM Analysis
Exhibit 
6.1
Target Addressable Indonesia Pharmacy Retail Market Outlook 
To 2025
TAM = USD XX Bn (Total national 
pharmacy revenue, estimated via 
population multiplied by forecasted per 
capita medicine spend.)
SAM = USD XX Bn (Serviceable retail 
subset: urban population share 
multiplied by per capita pharmacy 
spend and channel penetration.)
SOM = USD XX Bn (Serviceable 
obtainable share: chain 
retailers’ expected portion of 
SAM based on network reach 
and competition.)
Source: Ken Research Analysis
Note 1: The exhibit serves as an illustration, with numbers currently masked. The detailed statistics will be included in 
the final report.
Note 2: All revenue and financial numbers are for the current year.
COPYRIGHT KEN RESEARCH. ALL RIGHTS 
RESERVED
0
7
Ken Research 
Offerings
How can we add value 
?
Ken Research
Strategy & Transformation
▶ Digital transformation ▶ Portfolio & Growth 
strategy
Growth and Scale-Up Cost and Performance Excellence Customer Loyalty and Experience Investment Advisory
Expanding service offerings Reduction in operational Patient engagement ▶ Commercial due diligence
and treatment costs and retention ▶ Target screening
▶ Expansion of clinics and 
service locations ▶ Cost optimization in ▶ Digital engagement 
administrative with patients
▶ Specialization in niche processes
health services ▶ Telemedicine and 
▶ Streamlining online consultation
▶ Strategic partnerships patient 
with healthcare ▶ Personalization of management patient care
networks systems
▶ Optimizing scheduling 
and resource 
management
Enablement and Implementation
▶ Post-merger integration ▶ Health service 
management
▶ Integration of new technologies
COPYRIGHT KEN RESEARCH. ALL RIGHTS 
RESERVED
Ken Offerings
Our Solutions to Help Increase Stakeholder 
Value
Patient Experience & Retention Operational Efficiency Market Expansion & Growth
> Improve NPS, HCAHPS > Optimize workflows for > Expand services to 
scores with better care higher patient throughput. increase patient volume.
models.
> Enhance provider utilization > Use digital marketing to 
> Reduce wait times and with smart scheduling. boost new patient 
enhance follow up rates. acquisition.
> Reduce consultation time 
> Expand telehealth to while maintaining quality. > Develop corporate tie ups 
boost engagement and for contracted service 
retention. revenue.
Cost & Revenue Optimization Quality & Compliance Technology & Digital 
Integration
> Lower operating costs per > Ensure HIPAA, JCI, NABH
visit with better resource compliance. > Use AI to enhance 
use.
> Reduce medication errors and diagnostic accuracy.
> Improve billing effi ciency enhance adverse event > Improve EHR data 
and reduce claim reporting. interoperability and 
rejections.
> Maintain high clinical documentation.
> Maximize revenue per outcome scores. > Increase telemedicine 
provider with better adoption rates.
reimbursements.
Board to Frontline KPI 
Alignment
> Align cost per visit and 
EBITDA margin.
> Set provider 
performance 
benchmarks.
> Track treatment adherence 
and care continuity.
COPYRIGHT KEN RESEARCH. ALL RIGHTS 
RESERVED
▶Ken Research brings you industry-leading brand 
THOUGHT LEADERSHIP valuation, combined with research from the world’s
PATHWAYS This report is just the beginning. Connect with Ken Research experts, who track macroeconomic trends 
impacting global brands. Our library of over 20,000 
TO reports spans key markets like China, France, and the US, 
offering deep insights at kenresearch.com.
EXCEPTIONAL With over 200 experts and insights from 80+ countries, 
Ken Research provides the knowledge you need. Our 
GROWTH comprehensive approach combines innovative 
methodologies, consumer insights, creative content, and 
strategic media investments, optimizing your market 
presence and driving growth.
We are available to personally discuss how we can 
support you and your brand’s success. Feel free to 
contact me Sincerely,
Ankur Namit 
Gupta Goel
Partner & Founder Partner & Founder
[email protected] [email protected]
m m
COPYRIGHT KEN RESEARCH. ALL RIGHTS 
RESERVED
Research Methodology
1. Desk 2. Expert Interviews 3. Sanity Check 4. Forecasting 
Research Models Modeling
Conducted interviews 
Sources with industry experts, 
Applied a proxy model Developed a forecast  
pharmacists,  and retail 
using the number of model using historical  
Util ized industry managers to gain 
pharmacies, average data, growth drivers, 
reports, government insights into market 
revenue per pharmacy, and economic indicators 
publications, and dynamics, consumer 
and market penetration to project future market 
market databases to behavior, and regulatory 
rates to validate market trends and opportunities.
gather data on the impacts.
size estimates.
Indonesia Pharmacy 
Retail Market, including 
market size, growth 
trends, and competitive 
landscape.
SAMPLE SIZE BY 
STAKEHOLDERS
By Stakeholders Number of Respondents
C Level Executive ~ 
Respondents
Operational/Regional ~ 
Managers Respondents
Business Development / Sales ~ 
Manager Respondents
Other -Key opinion leaders from Associations, Warehouses, and 
s Manufacturing firms.
SAMPLE SIZE BY RESPONDENT CATEGORY IN 
PERCENTAGE (%)
C Level Executive - XX
%
Operational/Region
al Managers  - XX%
Business 
Development / Sales 
Manager - XX%
Others - XX%
COPYRIGHT KEN RESEARCH. ALL RIGHTS 
RESERVED
COPYRIGHT KEN RESEARCH. ALL RIGHTS 
RESERVED
COPYRIGHT KEN RESEARCH. ALL RIGHTS 
RESERVED
COPYRIGHT KEN RESEARCH. ALL RIGHTS 
RESERVED
CATEGORIE
S
AGRICULTURE AND ANIMAL CARE AUTOMOTIVE, TRANSPORTATION BANKING FINANCIAL SERVICES 
AND WAREHOUSING AND INSURANCE
▶ Agriculture Equipment
▶ Animal Care ▶ Automotive and Automotive ▶ Banking
Components
▶ Crop Protection ▶ Financial Services
▶ General Transportation
▶ Farming ▶ Insurance
▶ Logistics and Shipping
▶ Seed ▶ Loans and Advances
See More > See More >
See More >
PUBLIC SECTOR AND ADMINISTRATION ENERGY AND UTILITIES HEALTHCARE
▶ Legal Services ▶ Clean Technology ▶ Diagnostics
▶ Public Services ▶ Gas ▶ General Healthcare
▶ Religion ▶ Oil ▶ Medical Devices
▶ Power ▶ Pharmaceuticals
See More > See More > See More >
DEFENSE AND SECURITY METAL, MINING AND CHEMICALS Technology AND TELECOM
▶ Defense ▶ Chemicals ▶ IT and ITES
▶ Security Devices ▶  Metals & Minerals ▶ Telecommunications and Networking
▶ Weapon ▶ Mining
See More > See More > See More >
COPYRIGHT KEN RESEARCH. ALL RIGHTS 
RESERVED
CATEGORIE
S
EDUCATION AND RECRUITMENT FOOD, BEVERAGE AND TOBACCO MEDIA AND ENTERTAINMENT
▶ Education ▶ Alcoholic Beverages ▶ Advertising
▶ Recruitment ▶ Dairy Products ▶  Films and Animation
▶ Food Services ▶  Gaming and 
▶ General Food Gambling
Information Services, Newspaper 
▶ Non Alcoholic Beverages ▶ Magazines
and
▶ Tobacco Products ▶ Tourism
▶  TV, Radio and 
Broadcasting
See More > See More > See More 
>
MANUFACTURING AND CONSTRUCTION CONSUMER PRODUCTS AND 
RETAIL MARKET
▶ Construction Materials
▶ Industrial Engineering ▶ Baby Care
▶ Infrastructure ▶ Consumer Electronics
▶ Machinery and Parts ▶ Consumer Services
▶ Other Manufacturing Activities ▶ Cosmetics and Personal Care
▶ Real Estate ▶  Home and Office Furnishings
▶ Luxury Goods
▶ Sports Equipment
▶  Textile, Apparel and Footwear
▶ Wholesale and Retail
See More > See More >
COPYRIGHT KEN RESEARCH. ALL RIGHTS 
RESERVED
COPYRIGHT KEN RESEARCH. ALL RIGHTS 
RESERVED
CONTACT US
With 13 years of experience, we’ve served over 2,000 clients, including 70% of Fortune 500 We're here to help you find the right market insights and strategies. Our team is 
companies, delivering 20,000+ reports across 340+ industries. ready to support your needs and help your business grow.
For further information, please 
contact:
ANKUR GUPTA NAMIT GOEL
Partner & Founder Partner & Founder
[email protected] [email protected]
m m
+91 +91 
9311149880 9311149880
INDIA (IN) INDONESIA (ID)
Unit 14, Tower B3, Spaze i Tech# Business Park, Sohna Road, The Icon BSD City, Jl. Verdant View IIIA No.15, Tangera Regency, Province Banten-15345, 
sector 49 Gurgaon, Haryana - 122001, India Indonesia
UNITED ARAB EMIRATES (UAE) QATAR
105, Al Jaz1, Street no 2 the Greens Dubai United Art Office no. 9, Building no. 171, Zone no. 42, Street no. 230, Al-Rehab Complex, C-Ring road 
Emirates. Doha, Qatar - PO Box no. 30867